Volitionrx (VNRX) Change in Account Payables (2011 - 2012)
Volitionrx's (VNRX) quarterly Change in Account Payables came in at -$60173.0 in Q3 2012, down 18.31% YoY from -$73663.2 in Q4 2011, and up 33.74% on a QoQ basis from -$90816.0 in Q2 2012.
Volitionrx (VNRX) Change in Account Payables (2011 - 2012) Analysis & Trends
Volitionrx (VNRX) has 2 years of Change in Account Payables data on file, last reported at -$60173.0 in Q3 2012.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 71.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | -200.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | - |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 4.30 Mn |
| 10 | Volitionrx | 1.19 Mn | -1.60 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2012 | -60,173.00 |
| Sep 30, 2012 | -60,173.00 |
| Jun 30, 2012 | -90,816.00 |
| Jun 30, 2012 | -90,816.00 |
| Mar 31, 2012 | 66,908.00 |
| Mar 31, 2012 | 66,908.00 |
| Sep 30, 2011 | -50,859.00 |
| Sep 30, 2011 | -50,859.00 |
| Jun 30, 2011 | -3,684.00 |
| Jun 30, 2011 | -3,684.00 |
| Mar 31, 2011 | 19,869.00 |
| Mar 31, 2011 | 19,869.00 |